DeepLook Medical Wins Top Prize at Venture Madness 2026
DeepLook Medical has received top honors at the 2026 Venture Madness pitch competition, announced in a press release. The company develops AI imaging software for early cancer detection and has been expanding its operations in Arizona with the support of Xcellerant Ventures.
DeepLook’s FDA cleared software, DL Precise, provides radiologists with one click tumor segmentation and morphological displays. The software uses AI shape recognition to define tumor boundaries, particularly in dense breast tissue, to support early diagnosis.
Since relocating to Arizona, DeepLook has integrated into the local healthcare network and scaled its clinical operations, including collaborations with Banner MD Anderson. The hospital will serve as lead researcher for an upcoming breast surgery trial. Xcellerant Ventures’ first investment in women’s health supported DeepLook’s growth and connection to Arizona’s life sciences ecosystem.
The Venture Madness award, supported by the Arizona Innovation Challenge, marks a milestone for DeepLook’s expansion in the region and its continued focus on women’s health imaging technologies.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 20 IDC Names ZS a Leader in Life Sciences Evidence Services Sep 20 Brainomix Selected for UK Future Fifty Programme Sep 19 Rutgers and RWJBarnabas Health Launch AWS Health Innovation Hub Sep 19 Vetology Rebuilds 94 Veterinary Radiology AI Classifiers Sep 19 NAVER D2SF Backs ImpriMed in $10 Million Bridge RoundLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Market Logic Software Launches DeepSights Radar for Market Monitoring
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
Linearis Joins Two Canadian AI Health Data Projects
CATL Leads DeepCtrls Series B+ Funding Round
Daily AI Brief: the AI news that matters, in your inbox.